Page 7 of 9
The Journal of Organic Chemistry
1
10:1) afforded 6k as a white solid (38 mg, 66%). H NMR (400
δ 144.6, 134.4, 131.3, 129.8, 128.2, 127.7, 127.6, 122.8, 82.2, 70.7,
51.3, 27.4, 22.9, 21.6; MS (ESI) m/z [M + Na]+: 633.
1
2
3
4
5
6
7
8
MHz, CDCl3) δ 8.01–7.94 (m, 2H), 7.38–7.33 (m, 2H), 7.32–7.27
(m, 4H), 7.26 (s, 1H), 3.17 (s, 3H); 13C{1H} NMR (100 MHz,
CDCl3) δ 165.9 (JC-F = 254.8 Hz), 132.3, 131.5, 130.6 (JC-F = 9.6
Hz), 128.3, 128.1, 122.4, 116.5 (JC-F = 22.6 Hz), 83.5, 69.3, 39.4;
MS (EI) m/z 289, 276, 178, 130, 89, 63.
N, 4-Dimethyl-N-(o-tolylethynyl)benzenesulfonamide (7a).16
Purification by chromatography (petroleum ether/EtOAc = 10:1)
1
afforded 7a as a white solid (52 mg, 87%). H NMR (400 MHz,
CDCl3) δ 7.82 (d, J = 8.2 Hz, 2H), 7.36–7.26 (m, 3H), 7.13 (d, J =
4.0 Hz, 2H), 7.09–7.04 (m, 1H), 3.14 (s, 3H), 2.39 (s, 3H), 2.35 (s,
3H); 13C{1H} NMR (100 MHz, CDCl3) δ 145.0, 139.7, 133.4,
131.4, 129.9, 129.5, 127.9, 127.8, 125.6, 122.6, 87.9, 68.1, 39.5,
21.6, 20.7; MS (EI) m/z 299, 144, 115, 103, 77, 51.
4-Chloro-N-methyl-N-(phenylethynyl)benzenesulfonamide
(6l).16 Purification by chromatography (petroleum ether/EtOAc =
1
10:1) afforded 6l as a white solid (56 mg, 92%). H NMR (400
MHz, CDCl3) δ 7.89 (d, J = 8.6 Hz, 2H), 7.56 (d, J = 8.6 Hz, 2H),
7.39–7.34 (m, 2H), 7.32–7.27 (m, 3H), 3.17 (s, 3H);13C{1H} NMR
(100 MHz, CDCl3) δ 140.5, 134.7, 131.5, 129.6, 129.2, 128.4,
128.1, 122.4, 83.4, 69.4, 39.4; MS (EI) m/z 305, 226, 165, 130, 105,
89, 63.
N, 4-Dimethyl-N-(m-tolylethynyl)benzenesulfonamide (7b).16
Purification by chromatography (petroleum ether/EtOAc = 10:1)
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
1
afforded 7b as a white solid (54 mg, 90%). H NMR (400 MHz,
CDCl3) δ 7.84 (d, J = 8.2 Hz, 2H), 7.37 (d, J = 8.0 Hz, 2H), 7.21–
7.13 (m, 3H), 7.09 (d, J = 6.2 Hz, 1H), 3.14 (s, 3H), 2.46 (s, 3H),
2.31 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 144.7, 137.9,
133.4, 132.0, 129.8, 128.7, 128.4, 128.1, 127.9, 122.5, 83.6, 69.2,
39.3, 21.6, 21.2; MS (EI) m/z 299, 220, 144, 119, 103, 77, 51.
N, 4-Dimethyl-N-(p-tolylethynyl)benzenesulfonamide (7c).16
Purification by chromatography (petroleum ether/EtOAc = 10:1)
3-(Phenylethynyl)oxazolidin-2-one (6m).16 Purification by
chromatography (petroleum ether/EtOAc = 10:1) afforded 6m as a
white solid (26 mg, 70%). 1H NMR (400 MHz, CDCl3) δ 7.47–7.41
(m, 2 H), 7.33–7.28 (m, 3 H), 4.49-4.45 (m, 2 H), 4.03–3.95 (m, 2
H); 13C{1H} NMR (100 MHz, CDCl3) δ 156.0, 131.6, 128.4, 128.2,
122.2, 79.0, 71.2, 63.1, 47.1; MS (EI) m/z 187, 143, 115, 88, 77,
51.
1
afforded 7c as a white solid (51 mg, 85%). H NMR (400 MHz,
(R)-4-phenyl-3-(phenylethynyl)oxazolidin-2-one
(6n).16
CDCl3) δ 7.84 (d, J = 8.2 Hz, 2H), 7.36 (d, J = 8.2 Hz, 2H), 7.26
(d, J = 8.0 Hz, 2H), 7.09 (d, J = 8.0 Hz, 2H), 3.14 (s, 3H), 2.45 (s,
3H), 2.33 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 144.8, 138.1,
133.3, 131.5, 129.8, 129.1, 127.9, 119.6, 83.3, 69.1, 39.4, 21.7, 21.4;
MS (EI) m/z 299, 253, 144, 103, 77, 51.
N-((4-Methoxyphenyl)ethynyl)-N,4-dimethylbenzenesulfonam-
ide (7d).16 Purification by chromatography (petroleum ether/EtOAc
= 10:1) afforded 7d as a white solid (53 mg, 84%). 1H NMR (400
MHz, CDCl3) δ 7.83 (d, J = 8.0 Hz, 2H), 7.37 (d, J = 8.0 Hz, 2H),
7.31 (d, J = 8.8 Hz, 2H), 6.82 (d, J = 8.8 Hz, 2H), 3.80 (d, J = 4.3
Hz, 3H), 3.13 (s, 3H), 2.46 (s, 3H); 13C{1H} NMR (100 MHz,
CDCl3) δ 159.6, 144.7, 133.4, 129.8, 129.7, 127.9, 114.6, 113.9,
82.5, 68.7, 55.3, 39.4, 21.6; MS (EI) m/z 315, 236, 160, 119, 91,
65.
N-((4-(Tert-butyl)phenyl)ethynyl)-N,4-dimethylbenzenesulfon-
amide (7e).16 Purification by chromatography (petroleum
ether/EtOAc = 10:1) afforded 7e as a white solid (59 mg, 87%). 1H
NMR (400 MHz, CDCl3) δ 7.83 (d, J = 8.2 Hz, 2H), 7.34 (d, J =
8.2 Hz, 2H), 7.30 (s, 4H), 3.12 (s, 3H), 2.43 (s, 3H), 1.29 (s, 9H);
13C{1H} NMR (100 MHz, CDCl3) δ 151.3, 144.8, 133.3, 131.4,
129.8, 127.9, 125.3, 119.7, 83.4, 69.1, 39.4, 34.7, 31.2, 21.7; MS
(EI) m/z 341, 326, 186, 171, 145, 115, 91.
Purification by chromatography (petroleum ether/EtOAc = 10:1)
afforded 6n as a white solid (43.6 mg, 83%). 1H NMR (400 MHz,
CDCl3) δ 7.55–7.36 (m, 5H), 7.30–7.17 (m, 5H), 5.14 (dd, J = 8.5,
7.2 Hz, 1H), 4.78 (t, J = 8.8 Hz, 1H), 4.31 (dd, J = 8.9, 7.1 Hz, 1H);
13C{1H} NMR (100 MHz, CDCl3) δ 155.5, 136.1, 131.5, 129.6,
129.3, 128.1, 128.1, 126.9, 122.2, 78.0, 72.9, 70.7, 62.3; MS (EI)
m/z 263, 218, 178, 128, 89, 77.
1-(Phenylethynyl)-1H-pyrrolo[2,3-b]pyridine
(6o).16
Purification by chromatography (petroleum ether/EtOAc = 10:1)
afforded 6o as a Colorless liquid (37 mg, 85%). 1H NMR (400 MHz,
CDCl3) δ 8.46 (dd, J = 4.8, 1.4 Hz, 1H), 7.92 (dd, J = 7.8, 1.4 Hz,
1H), 7.70–7.56 (m, 2H), 7.43–7.31 (m, 4H), 7.18 (dd, J = 7.8, 4.8
Hz, 1H), 6.57 (d, J = 3.6 Hz, 1H); 13C{1H} NMR (100 MHz, CDCl3)
δ 149.5, 144.8, 132.0, 129.7, 129.6, 128.3, 122.4, 120.3, 118.0,
103.7, 100.0, 79.2, 71.7; MS (EI) m/z 218, 190, 163, 109, 91, 63.
9-(Phenylethynyl)-9H-carbazole (6p).16 Purification by
chromatography (petroleum ether/EtOAc = 10:1) afforded 6p as a
Colorless liquid (48 mg, 89%). 1H NMR (400 MHz, CDCl3) δ 8.01
(d, J = 7.6 Hz, 2H), 7.71 (d, J = 8.0k Hz, 2H), 7.65–7.59 (m, 2H),
7.55–7.47 (m, 2H), 7.41–7.31 (m, 5H); 13C{1H} NMR (100 MHz,
CDCl3) δ 140.5, 131.5, 128.5, 128.0, 126.8, 123.6, 123.0, 122.1,
120.4, 111.3, 78.9, 74.7; MS (EI) m/z 267, 225, 207, 191, 155, 91,
80.
N-((4-Fluorophenyl)ethynyl)-N,4-dimethylbenzenesulfonamide
(7f).16 Purification by chromatography (petroleum ether/EtOAc =
1
1-(Phenylethynyl)-1H-indole
(6q).16
Purification
by
10:1) afforded 7f as a white solid (46 mg, 76%). H NMR (400
chromatography (petroleum ether/EtOAc = 10:1) afforded 6q as a
Colorless liquid (40 mg, 92%). 1H NMR (400 MHz, CDCl3) δ 7.69–
7.51 (m, 4H), 7.45–7.30 (m, 4H), 7.29–7.18 (m, 2H), 6.67–6.54 (m,
1H); 13C{1H} NMR (100 MHz, CDCl3) δ 138.2, 131.5, 128.9,
128.5, 128.1, 127.9, 123.6, 122.7, 122.1, 121.3, 111.4, 105.6, 80.9,
70.7; MS (EI) m/z 217, 189, 163, 139, 108, 94.
MHz, CDCl3) δ 7.83 (d, J = 8.2 Hz, 2H), 7.42–7.30 (m, 4H), 6.97
(dd, J = 12.0, 5.2 Hz, 2H), 3.14 (s, 3H), 2.46 (s, 3H); 13C{1H} NMR
(100 MHz, CDCl3) δ 162.3 (JC-F = 247.6 Hz), 144.8 (JC-F = 5.8 Hz),
133.5 (JC-F = 8.2 Hz), 133.3, 129.9, 127.8, 118.8, 115.5 (JC-F = 22.0
Hz), 83.6, 68.0, 39.3, 21.6; MS (EI) m/z 303, 224, 148, 107, 91, 65.
N-((4-Chlorophenyl)ethynyl)-N,4-dimethylbenzenesulfonamide
(7g).16 Purification by chromatography (petroleum ether/EtOAc =
3-Methyl-1-(phenylethynyl)-1H-indole (6r).16 Purification by
chromatography (petroleum ether/EtOAc = 10:1) afforded 6r as a
Colorless liquid (43 mg, 92%). 1H NMR (400 MHz, CDCl3) δ 7.66–
7.49 (m, 4H), 7.39–7.31 (m, 4H), 7.24 (dd, J = 5.8, 2.0 Hz, 1H),
7.03 (d, J = 1.0 Hz, 1H), 2.32 (d, J = 1.0 Hz, 3H); 13C{1H} NMR
(100 MHz, CDCl3) δ 138.5, 131.3, 128.7, 128.4, 127.8, 125.8,
123.5, 123.0, 121.5, 119.3, 114.9, 111.3, 81.2, 70.4, 9.6; MS (EI)
m/z 231, 202, 178, 131, 91, 51.
N,N'-(Pentane-1,5-diyl)bis(4-methyl-N-(phenylethynyl)benze-
nesulfonamide) (6s).16 Purification by chromatography (petroleum
ether/EtOAc = 10:1) afforded 6s as a white solid (89 mg, 73%). 1H
NMR (400 MHz, CDCl3) δ 7.86 (d, J = 8.2 Hz, 4H), 7.44–7.36 (m,
8H), 7.34–7.28 (m, 6H), 3.42 (t, J = 7.2 Hz, 4H), 2.47 (s, 6H), 1.82-
1.69 (m, 4H), 1.51-1.44 (m, 2H);13C{1H} NMR (100 MHz, CDCl3)
1
10:1) afforded 7g as a white solid (50 mg, 79%). H NMR (400
MHz, CDCl3) δ 7.82 (d, J = 8.2 Hz, 2H), 7.37 (d, J = 8.0 Hz, 2H),
7.30–7.23 (m, 4H), 3.14 (s, 3H), 2.46 (s, 3H); 13C{1H} NMR (100
MHz, CDCl3) δ 144.9, 133.8, 133.3, 132.6, 129.7, 128.6, 127.8,
121.3, 84.9, 68.2, 39.2, 21.7; MS (EI) m/z 319, 280, 207, 167, 135,
88, 61.
N-((4-Bromophenyl)ethynyl)-N,4-dimethylbenzenesulfonamide
(7h).16 Purification by chromatography (petroleum ether/EtOAc =
1
10:1) afforded 7h as a white solid (54 mg, 74%). H NMR (400
MHz, CDCl3) δ 7.81 (d, J = 8.2 Hz, 2H), 7.46–7.33 (m, 4H), 7.20
(d, J = 8.4 Hz, 2H), 3.14 (s, 3H), 2.45 (s, 3H); 13C{1H} NMR (100
MHz, CDCl3) δ 144.9, 133.3, 132.7, 131.5, 129.9, 127.8, 121.9,
121.8, 85.1, 68.3, 39.2, 21.7; MS (EI) m/z 363, 284, 208, 167, 114,
91, 65.
ACS Paragon Plus Environment